Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2008-04-02

Clinical Trial Update: The OMEGA Study: Use of Eye Drops to Treat Geographic Atrophy Associated With Age-Related Macular Degeneration (Dry AMD) [Phase 2]

View source ↗

Summary

This clinical trial update reports on a Phase 2 study (OMEGA) evaluating an eye drop treatment for geographic atrophy linked to age-related macular degeneration…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eye drops used in OMEGA study

Snippet

Sponsor: Othera Pharmaceuticals | Conditions: Age-Related Macular Degeneration | Phase 2 | Status: UNKNOWN